Results 101 to 110 of about 2,823 (147)

Effect of evolocumab on the gut microbiota in patients with acute myocardial infarction. [PDF]

J Med Microbiol
Zou J, Peng Y, Cai H, Zhong Q, Zhu N, Gu W, Yang F, Shi T, Yang S, Chen L.   +9 more
europepmc   +1 more source

[Modification of the prescription of anticholesteremic agents]. [PDF]

Aten Primaria, 2001
Luque Garrocho A, Hernández Jiménez MJ, Charques Velasco E, Alonso Martínez MM.   +3 more
europepmc   +1 more source

Neuartige Lebensmittel [PDF]

, 1997
Geisen, Rolf, Holzapfel, Wilhelm Heinrich   +1 more
core  

Efeitos pleiotrópicos das estatinas na sepse

, 2014
Kelly Cristina Batista de Souto Queiroz, Luiz Carlos de Abreu, Mônica Akemi Sato, Rodrigo Daminello Raimundo, Silvana Menegoto Nogueira Di Giusto   +4 more
core   +1 more source

Achieving LDL-Cholesterol Goals: Can Implementation Science Save Us? [PDF]

Arq Bras Cardiol
Cesena FY.
europepmc   +1 more source

Treatment with PCSK9 monoclonal antibodies is associated with discontinuation of oral lipid lowering therapy. [PDF]

Eur Heart J Qual Care Clin Outcomes
Engebretsen I, Ødegaard KM, Halvorsen S, Bugge C, Kristiansen IS, Støvring H, Munkhaugen J.   +6 more
europepmc   +1 more source

Efficacy and safety of PCSK-9 inhibitors in patients with acute coronary syndrome: a systematic review and network meta-analysis. [PDF]

BMC Cardiovasc Disord
Kao G, Chen C, Zhang Y, Xu Y, Xu G.
europepmc   +1 more source

High-Intensity Statin versus Upfront Equivalent-Dose Combination of Moderate-Intensity Statin with Ezetimibe Following Acute Myocardial Infarction (ROSUZET-AMI): protocol of a multicentre, open-label, randomised non-inferiority trial. [PDF]

BMJ Open
Choo EH, Kim CJ, Hwang BH, Lee KY, Oh GC, Lim S, Choi IJ, Kim DB, Kwon OS, Lee S, Choi Y, Park CS, Park MW, Kim HY, Lee HC, Kang TS, Sung JK, Woo SI, Park HS, Yun KH, Chang K, ROSUZET-AMI investigator.   +21 more
europepmc   +1 more source

Implementation of a nonstatin prior authorization checklist for patients with hypercholesterolemia: In 2 community health care systems. [PDF]

J Manag Care Spec Pharm
McCormick D, Taub PR, Carter J, Moreo K, Heggen CL.   +4 more
europepmc   +1 more source

Efficacy and safety of switching to ezetimibe 10 mg/rosuvastatin 2.5 mg in Korean patients with type 2 diabetes mellitus and dyslipidaemia: A multicentre, prospective study (EROICA study). [PDF]

Diabetes Obes Metab
Hong S, Kim WJ, Kim S, Park JH, Kang ES, Moon MK, Kim JT, Mok JO, Lee KY, Park CY, Lee CB.   +10 more
europepmc   +1 more source